There are 2789 resources available
Optimising the management of patients with advanced prostate cancer: Key questions in 2021
Presenter: Steven Joniau
Session: Janssen - A Decade’s Perspective on Advances in Prostate Cancer
Resources:
Webcast
Vision for the future
Presenter: Johann de Bono
Session: Janssen - A Decade’s Perspective on Advances in Prostate Cancer
Resources:
Webcast
Close of meeting
Presenter: Laura-Maria Krabbe
Session: Janssen - A Decade’s Perspective on Advances in Prostate Cancer
Resources:
Webcast
Welcome and Introductions
Presenter: Andrea Necchi
Session: Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
Resources:
Webcast
Recurrence Post-Radical Resection: Are Systemic Therapies the Solution to Optimize Patient Outcomes?
Presenter: Andrea Necchi
Session: Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
Resources:
Webcast
Biomarkers: Are We Ready to Use Them in Routine Clinical Practice?
Presenter: Matthew Galsky
Session: Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
Resources:
Webcast
QoL: Is It a Key Endpoint in the Adjuvant Setting?
Presenter: Matthew Galsky
Session: Bristol Myers Squibb - Latest advances in Muscle Invasive Urothelial Carcinoma: How Will They Impact Our Daily Practice?
Resources:
Webcast
Full session recording
Presenter: Nicoletta Colombo
Session: AstraZeneca - Redefining long-term outcomes in newly diagnosed advanced ovarian cancer: Expert perspectives on integrating personalized medicine
Resources:
Webcast
Is a one size fits all approach still appropriate for NSCLS with an EGFR mutation, are all mutations equal?
Presenter: Joachim Aerts
Session: Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
Resources:
Webcast
Scientific rationale for dual inhibition of VEGF and EGFR
Presenter: Nobuyuki Takakura
Session: Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
Resources:
Webcast